MedPath

A prospective randomized comparative trial of covered self-expandable metallic stents with 12mm and 10mm diameters for the distal biliary obstructions in unresectable malignancies

Phase 2
Conditions
unresectable distal biliary malignancies
Registration Number
JPRN-UMIN000016911
Lead Sponsor
BORE Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
74
Inclusion Criteria

Not provided

Exclusion Criteria

1) patients with massive ascites 2) patients with severe comorbidities in other organs 3) prior biliary SEMS placement 4) patients with surgically altered anatomy 5) difficulty to achieve biliary cannulation during endoscopic retrograde cholangiography 6) intestinal obstruction distal to the ampulla 7) patients with pregnancy 8) patients considered ineligible by attending physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stent occlusion rate and dysfunction rate at 180 days after stent deployment
Secondary Outcome Measures
NameTimeMethod
1) Stent patency duration 2) Time to recurrent biliary obstruction (TRBO) 3) Overall stent patency rate and function rate 4) Median survival time 5) Stent-related complication rate
© Copyright 2025. All Rights Reserved by MedPath